CG Oncology (CGON) FCF Margin (2023 - 2026)
CG Oncology (CGON) posted FCF Margin of 5281.99% for Q1 2026, down 238.74% on a QoQ basis from 1559.3% in Q4 2025, and up 5105070.0% year-over-year from N/an in Q1 2025.
CG Oncology (CGON) FCF Margin (2023 - 2026) Analysis & Trends
CG Oncology's FCF Margin history runs 4 years deep, the most recent figure standing at 5281.99% for Q1 2026.
- Quarterly FCF Margin rose 5105070.0% year-over-year to 5281.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3162.0% (up 925734.0% YoY) and the FY2025 annual result came in at 3278.07%, up 365319.0% from the prior year.
- FCF Margin was 5281.99% for Q1 2026 at CG Oncology, down from 1559.3% in the prior quarter.
- Across five years, FCF Margin topped out at 1559.3% in Q4 2025 and bottomed at 1464500.0% in Q4 2023.
- A 4-year average of 157402.16% and a median of 5281.99% in 2026 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin surged 145992303 bps — and 2025, when it tumbled 5141322 bps.
- CG Oncology's FCF Margin stood at 1464500.0% in 2023, then soared by 100 bps to 4576.97% in 2024, then surged by 66 bps to 1559.3% in 2025, then plunged by 239 bps to 5281.99% in 2026.
- Business Quant data shows CGON's FCF Margin at 5281.99% in Q1 2026, 1559.3% in Q4 2025, and 2338.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn | -5,281.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,281.99% |
| Dec 31, 2025 | -1,559.30% |
| Sep 30, 2025 | -2,338.60% |
| Mar 31, 2025 | -56,332.69% |
| Dec 31, 2024 | -4,576.97% |
| Sep 30, 2024 | -37,018.60% |
| Jun 30, 2024 | -14,535.14% |
| Mar 31, 2024 | -4,919.47% |
| Dec 31, 2023 | -1,464,500.00% |
| Sep 30, 2023 | -136,244.44% |
| Mar 31, 2023 | -4,116.49% |